![Michael Jerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jerman
Directeur/Membre du Conseil chez
HEDGEPATH PHARMACEUTICALS INC
Fortune : 56 447 $ au 31/08/2026
Profil
Michael A. Jerman is currently an Independent Director at Alaunos Therapeutics, Inc. since 2025, an Independent Director at Inhibitor Therapeutics, Inc. since 2023, and Managing Partner at Hollywell Partners LLC since 2019.
Former roles include Independent Director at MIRA Pharmaceuticals, Inc. from 2023 to 2024, Independent Director at Telomir Pharmaceuticals, Inc. from 2023 to 2024, and Director at PricewaterhouseCoopers LLP from 2007 to 2019.
Education includes an MBA from the University of Oxford, undergraduate studies at the University of South Florida, and graduate studies at The University of Tampa, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/07/2026 | 23 759 ( 0,94 % ) | 40 390 $ | 31/08/2026 | |
| 17/08/2026 | 180 411 ( 0,1 % ) | 16 057 $ | 31/08/2026 |
Postes actifs de Michael Jerman
| Sociétés | Poste | Début |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Directeur/Membre du Conseil | 24/05/2023 |
| ALAUNOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2025 |
HOLLYWELL PARTNERS LLC
 HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Corporate Officer/Principal | 01/05/2019 |
Anciens postes connus de Michael Jerman
| Sociétés | Poste | Fin |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/11/2024 |
| MIRA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/11/2024 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Directeur/Membre du Conseil | 01/08/2019 |
Formation de Michael Jerman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tampa, Inc.
 The University of Tampa, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
HOLLYWELL PARTNERS LLC
HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Commercial Services |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
